Qube Research & Technologies LTD Heska Corp Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$60.21 - $77.74 $690,247 - $891,211	11,464 Added 355.25%	14,691 $913,000
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $85,681 - $117,182	-1,175 Reduced 26.69%	3,227 $235,000
Q2 2022 Aug 15, 2022	BUY	$84.23 - $147.57 $370,780 - $649,603	4,402 New	4,402 $416,000
Q4 2021 Feb 01, 2022	SELL	$156.0 - $265.78 $234,780 - $399,998	-1,505 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$228.69 - $274.2 $492,140 - $590,078	-2,152 Reduced 58.85%	1,505 $389,000
Q2 2021 Aug 13, 2021	BUY	$169.89 - $231.37 $191,635 - $260,985	1,128 Added 44.6%	3,657 $840,000
Q1 2021 May 14, 2021	BUY	$143.93 - $207.3 $119,605 - $172,266	831 Added 48.94%	2,529 $426,000
Q4 2020 Feb 16, 2021	SELL	$96.1 - $151.18 $47,665 - $74,985	-496 Reduced 22.61%	1,698 $247,000
Q3 2020 Nov 12, 2020	BUY	$90.16 - $107.61 $197,811 - $236,096	2,194 New	2,194 $217,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.